Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D6ZM5N
|
|||
Drug Name |
APZ-2
|
|||
Drug Type |
Cell therapy
|
|||
Indication | Epidermolysis bullosa [ICD-11: EC3Z] | Phase 3 | [1] | |
Company |
RHEACELL
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT05838092) A Double-blind, Randomized, Placebo-controlled, Interventional, Multicenter, Phase III Clinical Trial to Investigate the Safety and Efficacy of ABCB5-positive Mesenchymal Stromal Cells (ABCB5+ MSCs) on Epidermolysis Bullosa (EB). U.S.National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.